BACKGROUND Standard immunosuppressive regimens result in low rejection rates in the first year after transplantation. However, long-term survival rates after renal transplantation remain relatively poor and are associated with drug-induced side effects. AIM To assess the effects of switching from traditional mycophenolate mofetil (MMF) combined with steroids and tacrolimus to a low-dose regimen of everolimus and tacrolimus in post-kidney transplant patients, with the aim of reducing the adverse